文献速递眼底病与葡萄膜炎

长链非编码RNA与糖尿病视网膜病变:当前认识、未来方向与挑战

Long noncoding RNAs and diabetic retinopathy: Current understanding, future directions and challenges.
PubMed 文献 · Prog Retin Eye Res · 2026-08-21

糖尿病视网膜病变是工作年龄人群可预防性失明的主要原因,其病理涉及代谢、血流动力学和表观遗传通路的复杂交互。糖尿病导致包括微小RNA和长链非编码RNA在内的多种非编码RNA差异表达,其中MALAT1、MEG3、HOTAIR、MIAT1和H19等长链非编码RNA的异常表达与糖尿病视网膜病变的代谢异常相关。长链非编码RNA在循环中释放、具有高器官和细胞特异性、在血浆中稳定表达,使其成为有前景的诊断或预后标志物及治疗靶点。

要点

  • 糖尿病视网膜病变是工作年龄人群可预防性失明的主要原因,病理涉及代谢、血流动力学和表观遗传通路交互。
  • MALAT1、MEG3、HOTAIR、MIAT1和H19等长链非编码RNA的异常表达与糖尿病视网膜病变的代谢异常相关。
  • 长链非编码RNA在血浆中稳定表达、具有高器官和细胞特异性,是潜在的诊断/预后标志物和治疗靶点。

核心结论

  • 长链非编码RNA作为糖尿病视网膜病变的生物标志物和基于长链非编码RNA的治疗手段,前景广阔。

研究设计与样本

  • 综述性文章,总结了长链非编码RNA在糖尿病视网膜病变中的当前认识、未来方向与挑战。

主要发现

  • 糖尿病导致包括微小RNA和长链非编码RNA在内的多种非编码RNA差异表达。
  • 人类基因组中已鉴定超过30000个长链非编码RNA转录本,而微小RNA约2000个。
  • 大多数长链非编码RNA的功能和作用机制尚未完全阐明,且同一长链非编码RNA在不同背景下可能具有不同功能。
  • 长链非编码RNA主要非编码,但具有多种调节功能,通过与DNA、RNA和蛋白质相互作用调节基因表达。
  • MALAT1、MEG3、HOTAIR、MIAT1和H19等长链非编码RNA的异常表达与糖尿病视网膜病变的代谢异常相关。

关键数值与推荐

  • 长链非编码RNA作为诊断或预后标志物及治疗靶点的潜力基于其在血浆中的稳定表达、高器官和细胞特异性以及与疾病相关的差异。

临床怎么用

  • 长链非编码RNA有潜力作为糖尿病视网膜病变的诊断或预后标志物。
  • 长链非编码RNA可作为糖尿病视网膜病变的治疗靶点,基于长链非编码RNA的治疗手段前景广阔。

局限性

  • 大多数长链非编码RNA的功能和作用机制尚未完全阐明。
  • 同一长链非编码RNA在不同背景下可能具有不同功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic retinopathy remains as the leading cause of preventable blindness in working-aged people. The pathophysiology of this sight-threatening disease is complex and involves intricate interactions among metabolic, hemodynamic and epigenetic pathways, leading to molecular, structural, functional and genomic abnormalities in retinal vascular and nonvascular cells. Diabetes also results in differential expressions of several noncoding RNAs, including micro RNAs (miRNAs) and long noncoding RNAs (LncRNAs). Compared to about 2000 miRNA identified in human genome thus far, more than 30,000 LncRNA transcripts have been already identified, but the function and mechanism of action of most of the LncRNAs is still not fully characterized, and there remains a possibility that some LncRNAs could have diverse functions under different contexts. LncRNAs are mainly noncoding, but they have many regulatory functions, and regulate gene expression by interacting with DNA, RNA and protein. Aberrant expressions of several LncRNAs including MALAT1, MEG3, HOTAIR, MIAT1 and H19, is associated with metabolic abnormalities implicated in the pathogenesis of diabetic retinopathy. LncRNAs are also released into circulation and show high organ and cell specificity, and greater disease-associated differences compared to disease-associated mRNAs. Furthermore, LncRNAs maintain stable expression in the plasma and can be isolated from total RNA present in biological samples including blood, which makes them promising and reliable candidates for diagnostic or prognostic markers and therapeutic targets for various diseases. With continued improvement in innovative RNA modifications and delivery modalities, use of LncRNAs as possible biomarkers, and of LncRNA-based therapeutics, for diabetic retinopathy appears promising.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Kowluru RA, Kaur I, Wang S, et al. Long noncoding RNAs and diabetic retinopathy: Current understanding, future directions and challenges. Prog Retin Eye Res. 2026. PMID: 42628637. doi:10.1016/j.preteyeres.2026.101511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。